Purdue Pharma Clashes With DOJ Over Imperiled OxyContin Deal (1)

A $6 billion deal hung in the balance Friday as OxyContin maker Purdue Pharma LP and its wealthy owners squared off against the U.S. Justice Department over the firm’s opioid lawsuit settlement.

The sides met in a New York courtroom to argue over a plan to funnel billions of dollars to opioid crisis abatement efforts and settle trillions of dollars of legal claims against the drugmaker. Purdue Pharma won approval of the deal in bankruptcy court last year, but an appeals judge later threw out the accord in a shock decision. Now, a panel of higher-ranking judges is reviewing ...